Industry Supported Symposia Programmes

Industry Supported Symposia Programmes

​WEDNESDAY, 22 MAY 2019


THE ANGELS INITIATIVE: 3 YEARS AND COUNTING

SYMPOSIUM IS ORGANISED AND SUPPORTED BY  Boehringer Ingelheim / Angels Initiative

Wednesday, 22 May | 13:00-14:30 | Auditorium

Chairs: Georgios Tsivgoulis (Greece) and Andrea Zini (Italy)

13:00 - 13:15     THREE YEARS OF ANGELS
     Georgios Tsivgoulis (Greece)

13:15 - 13:30     SETTING UP A NEW STROKE READY HOSPITAL
    Salvatore Ascione (Italy)

13:30 - 13:45     ORGANISATION OF A REGIONAL STROKE NETWORK 
     Andrea Zini (Italy)

13:45 - 14:00     EMPOWERING STROKE NURSES
    Estela Sanjuan (Spain)

14:00 - 14:15     EMERGENCY MEDICAL SERVICES: THE ADVANCED STROKE LIFE SUPPORT® PROGRAM 
    Ivette Motola (USA)

14:15 - 14:00     ANGELS OUTSIDE EUROPE: A SUCCESS STORY FROM VIETNAM
     Nguyen Huy Thang (Vietnam)

--------------------------------------------------------------------------------

STROKE PREVENTION IN ELDERLY AF PATIENTS

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Daiichi Sankyo

Wednesday, 22 May | 13:00-14:30 | Space 1

Chair: Maurizio Paciaroni (Italy)

13:00-13:10 WELCOME AND INTRODUCTION
                       Maurizio Paciaroni (Italy)

13:10-13:30 ANTICOAGULATION IN ELDERLY PATIENTS, DO THE BENEFITS OUTWEIGH THE RISKS?
                        Sigrun Halvorsen (Norway)

13:30-13:50 HOW TO INDIVIDUALIZE ANTICOAGULATION IN AGING AF PATIENTS
                       Florian Masuhr (Germany)

13:50-14:10 TIMING OF ANTICOAGULATION AFTER RECENT ISCHAEMIC OR HAEMORRHAGIC STROKE  
                       
Rónán Collins (Ireland)

14:10-14:30 PANEL DISCUSSION
                       Maurizio Paciaroni (Italy), Rónán Collins (Ireland), Florian Masuhr (Germany) and Sigrun                                           Halvorsen (Norway)

--------------------------------------------------------------------------------

BRAIN, HEART AND KIDNEYS: PRESERVING THE BALANCE IN STROKE PREVENTION

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Bayer

Wednesday22 May |13:00 – 14:30 | Space 2

Chair: Graeme Hankey (Australia)

13:00-13:15        OPENING & INTRODUCTION
                             
Graeme Hankey (Australia)

13:15-13:40        MANAGING YOUR AF PATIENT BEYOND STROKE PREVENTION: SHOULD WE  

                              CARE FOR THE KIDNEYS?

                              Hendrik Bonnemeier (Germany)  

13:40-13:50        DISCUSSION
                              
Graeme Hankey (Australia) and  Hendrik Bonnemeier (Germany)

13:50-14:15        DEFINING ‘HIGH RISK’ IN DIABETES PATIENTS: STROKE PREVENTION IN AF, CAD AND  PAD
     Mike Sharma (Canada)

14:15-14:25        DISCUSSION
                              Graeme Hankey (Australia) and Mike Sharma (Canada)

14:25-14:30      CLOSING REMARKS
                              
Graeme Hankey (Australia)

--------------------------------------------------------------------------------


HOW NOAC SELECTION AND REVERSAL CAN HELP PROTECT OUR PATIENTS:
YOUR QUESTIONS ANSWERED

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Boehringer Ingelheim

Wednesday22 May |13:00 – 14:00 | Space 3+4

Co-Chairs: Stephen Davis (Australia) and Martin Grond (Germany)

13:00-13:05      KEEPING PACE WITH ADVANCES IN ANTICOAGULATION 
                            
Stephen Davis (Australia)

13:05-13:20      WHAT IS THE EVIDENCE FOR DABIGATRAN?
   Richard Bernstein (USA)


13:20-13:23      QUICKFIRE Q&A
                                                                                           

13:23-13:38      WHAT IS THE EVIDENCE FOR NOAC REVERSAL STRATEGIES?
   Sheila Martins (Brazil)

13:38-13:41     QUICKFIRE Q&A

13:41-13:56      HOW DO WE MANAGE DABIGATRAN AND IDARUCIZUMAB IN NEUROLOGICAL                    EMERGENCIES?
  Martin Grond (Germany)

13:56-14:00     AUDIENCE QUESTIONS AND CLOSE 
   Stephen Davis (Australia) and Martin Grond (Germany)

--------------------------------------------------------------------------------

AFTER CARDIOEMBOLIC STROKE, MAKE PREVENTION THE PRIORITY!

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Abbott Structural Heart  

Wednesday, 22 May|13:00-14:30| Brown 1+2

Chairs:  Danilo Toni (Italy) and Hans-Christoph Diener (Germany)

13:00-13:05      INTRODUCTION AND AND OBJECTIVES
                            Danilo Toni (Italy) and Hans-Christoph Diener (Germany)          

13:05-13:15      CARDIOEMBOLIC STROKE: FROM PFO TO LAA 
   Hans-Christoph Diener (Germany)

13:15-13:35      PFO CLOSURE: CLINICAL EVIDENCES & GUIDELINES
   Jean Louis Mas (France)

13:35-13:40     DISCUSSION AND AUDIENCE INTERACTION
                            Danilo Toni (Italy) and Hans-Christoph Diener (Germany)

13:40-14:05      PFO CLOSURE EFFECTIVE PATIENT PATHWAY: SCREENING & IMAGING FOR APPROPRIATE               PATIENT SELECTION  
    Martin Swaans (The Netherlands)

14:05-14:10      DISCUSSION AND AUDIENCE INTERACTION
   Danilo Toni (Italy) and Hans-Christoph Diener (Germany)

14:10-14:25     LAA OCCLUSION IN PATIENTS WITH CONTRAINDICATIONS FOR                                      ANTICOAGULATION
  Per Wester (Sweden)

14:25-14:30     TAKE HOME MESSAGE       
  Danilo Toni (Italy) and Hans-Christoph Diener (Germany)

--------------------------------------------------------------------------------


PCSK9 INHIBITION: WHAT BENEFIT IN SECONDARY PREVENTION OF ISCHAEMIC STROKE?

SYMPOSIUM IS ORGANISED AND SUPPORTED BY  Amgen

Wednesday, 22 May | 13:00-14:30 |Brown 3

Chairs: Marcello Arca (Italy)

 13:00 - 13:10  VASCULAR RISK AFTER STROKE IN 2019: ARE WE DOING ENOUGH?
                           Marcello Arca (Italy)

 13:10 - 13:30  LIPID MANAGEMENT FOR STROKE PREVENTION: THE EVIDENCE
                           Gary Ford (UK) 

 13:30 - 13:50   PCSK9 INHIBITORS: LDL-C LOWERING AND SECONDARY STROKE PREVENTION
                           Christian Gerloff (Germany)

 13:50 - 14:10   PCSK9 INHIBITORS: LET’S GET REAL!
                                Haralampos Milionis (Greece)

 14:10 - 14:20   PANEL DISCUSSION
                            All

 14:20 - 14:30   TIME FOR ACTION!
                            Marcello Arca (Italy)  


​thursday, 23 MAY 2019

IMMEDIATE NEURORECOVERY TREATMENT IMPROVES LONGTERM OUTCOME

SYMPOSIUM IS ORGANISED AND SUPPORTED BY EVER Neuro Pharma

Thursday 23 May| 12:45 - 14:15| Auditorium

Chair: Dafin Muresanu (Romania)

12:45 - 13:10     CEREBROLYSIN-CHALLENGES & PERSPECTIVES IN NEURORECOVERY
                             Michael Brainin  (Austria)

13:10 - 13:30     DETECTING AND RECOGNIZING COGNITIVE IMPAIRMENT AFTER STROKE
                             Leonardo Pantoni (Itlay)        

13:30 - 13:55     THE IMPORTANCE OF EARLY MOBILIZATION AND REHABILITATION AFTER STROKE
                             Katharina Stibrant Sunnerhagen  (Sweden)

13:55 - 14:15     NEW HOPE FOR CHRONIC STROKE PATIENTS – THE IMPULSE STUDY
                             Andreas Winkler (Austria) 

--------------------------------------------------------------------------------

2020 VISION OF ACUTE ISCHAEMIC STROKE REPERFUSION: TIMING IS EVERYTHING

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Boehringer Ingelheim            

Thursday, 23 May|12:45-14:15| Space 1

Chairs:  Danilo Toni (Italy) and Sheila Martins (Brazil)

12:45-12:50    WELCOME & INTRODUCTION 
                          
Danilo Toni (Italy)       

12:50-13:05   CONTEMPORARY EVIDENCE TO HELP CLOSE THE GAP BETWEEN UPTAKE OF THROMBOLYSIS  AND PATIENT ELIGIBILITY
Kennedy Lees (UK)

13:05-13:10  DISCUSSION
Moderated by Danilo Toni (Italy) and Sheila Martins (Brazil)

13:10-13:25   EFFECTIVE ORGANISATION AND COMPARISON OF STROKE NETWORKS AROUND THE WORLD – EXPERIENCE FROM HELSINKI AND MELBOURNE
Atte Meretoja (Finland)

13:25-13:30   DISCUSSION 
Moderated by Danilo Toni (Italy) and Sheila Martins (Brazil)

13:30-13:45   WHEN LOCATION IS A CHALLENGE: HOW TO SUCCESSFULLY IMPLEMENT TELEMEDICINE  
Gisele Sampaio Silva (Brazil)              

13:45-13:50   DISCUSSION 
Moderated by Danilo Toni (Italy) and Sheila Martins (Brazil)

13:50-14:05   TIME STOPS FOR NO ONE: ARE WE ANY CLOSER TO REACHING THE 20/20/20 OBJECTIVE?       
Robert Mikulik (Czech Republic)            

14:05-14:15   DISCUSSION AND CONCLUDING REMARKS 
Danilo Toni (Italy) and Sheila Martins (Brazil)


--------------------------------------------------------------------------------

MEDTRONIC CARE CONTINUUM: IMPROVING PATIENT PATHWAY

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Medtronic

Thursday, 23 May|12:45-14:15| Space 2

12:45-13:15   RACECAT TRIAL: FIRST RESULTS
Marc Ribo (Spain)

13:15-13:45   PERSONALIZED MEDICINE IN STROKE: THE ROLE OF INSERTABLE CARDIAC MONITORS IN CRYPTOGENIC STROKE PATIENTS
G
eorgios Tsivgoulis (Greece)

13:45-14:15   REDUCE POST STROKE SPASTICITY WITH ITB THERAPY – NEW STUDY RESULTS  '
Geoffrey Cloud (Australia)


--------------------------------------------------------------------------------

ADVANCING STROKE TREATMENT: CURRENT TRENDS AND DEVELOPMENTS ALONG PATIENT PATHWAY SYSTEMS OF CARE

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Stryker

Thursday, 23 May | 12:45 – 14:15 | Space 3 + 4

Moderator: Gary Ford (UK)  

12:45-12:47    INTRODUCTION
                          Gary Ford (UK)  

12:47-13:07    IMAGING SELECTION FOR ENDOVASCULAR THROMBECTOMY: THE SELECT TRIAL
                          Amrou Sarraj (USA)

13:07-13:27    STREAM: MULTIDISCIPLINARY STROKE TEAM TRAINING IMPROVES PROCESS TIMES FOR                                       THROMBOLYSIS AND THROMBECTOMY
                          Waltraud Pfeilschifter (Germany)

13:27-13:47   IS MECHANICAL THROMBECTOMY STILL COST-EFFECTIVE WHEN TREATING LATE AND ELDERLY                             STROKE PATIENTS?
                         Kyriakos Lobotesis (UK)  

13:47-14:07    WEAVE INTRACRANIAL STENT TRIAL: FINAL TRIAL RESULTS IN 152 CONSECUTIVE PATIENTS                                   TREATED ON-LABEL
                          Michael J. Alexander (USA)

14:07-14:15   QUESTIONS


--------------------------------------------------------------------------------


STROKE MANAGEMENT AND PREVENTION IN AF: OUTLOOK IN 2019

SYMPOSIUM IS ORGANISED AND SUPPORTED BY BMS/Pfizer Alliance

Thursday, 23 May | 12:45-14:15 | Brown 1+2
Chair: 
Hans-Christoph Diener (Germany)

12:45-12:50 STROKE MANAGEMENT AND PREVENTION IN AF: OUTSTANDING QUESTIONS
                       Hans-Christoph Diener (Germany)

12:50-13:05  PRACTICAL MANAGEMENT OF ACUTE STROKE IN THE EMERGENCY ROOM 
                        Carlos Molina (Spain)
13:05-13:20  AFTER ACUTE STROKE: HOW HARD SHOULD WE LOOK FOR AF? 
                        Hans-Christoph Diener (Germany)

13:20-13:40  SECONDARY STROKE PREVENTION: HOW CAN NOACS IMPROVE PATIENT CARE?
                        Derek Connolly(UK)

13:40-14:00  SECONDARY STROKE PREVENTION IN AF: WHEN TO START ANTICOAGULATION
                        Maurizio Paciaroni (Italy)

14:00-14:15  PANEL DISCUSSION: BRINGING TOGETHER EVIDENCE AND EXPERIENCE TO IMPROVE PATIENT                              OUTCOMES
                         All

--------------------------------------------------------------------------------

POST-STROKE EPILEPSY: REALITY FOR THE PATIENT TODAY AND THE GOALS FOR TOMORROW

SYMPOSIUM IS ORGANISED AND SUPPORTED BY UCB Pharma 

Thursday 23 May | 12:45-14:15 | Brown 3

Chairs: Mar Carreño (Spain) and Antonio Gil-Nagel (Spain)


 12:45-13:00      CHAIR'S WELCOME AND INTRODUCTION
                            Mar Carreño (Spain) and Antonio Gil-Nagel (Spain)

 13:00-13:20      360° ON POST-STROKE EPILEPSY 
                              Martin Holtkamp (Germany) 

 13:20-13:40      ANTIEPILEPTIC TREATMENT OF PATIENTS LIVING WITH EPILEPSY AFTER STROKE
                             Francesco Brigo (Italy)

 13:40-14:10      FACILITATED DISCUSSION WITH THE AUDIENCE
                             Mar Carreno (Spain), Antonio Gil-Nagel (Spain), Martin Holtkamp (Germany)
                             and Francesco Brigo (Italy)

 14:10-14:15      CLOSING REMARKS
                             Mar Carreño (Spain) and Antonio Gil-Nagel (Spain)